Wednesday, May 24 2017 - 9:30pm
Wednesday, May 24 2017 - 9:00pm
Wednesday, May 24 2017 - 5:15pm
Wednesday, May 24 2017 - 4:00pm
Wednesday, May 24 2017 - 3:00pm
TEFLARO is the first and only cephalosporin indicated in adults and pediatric patients 2 months of age and older for the treatment of ABSSSI and CABP, $AGN said. It was in 2010 that the U.S. FDA had first approved TEFLARO to treat adults with CABP and ABSSSI
$ANIK announced the enrollment of the first patient in its supplemental Phase 3 trial evaluating the efficacy and safety of CINGAL, its novel HA-corticosteroid combination viscosupplement for the treatment of symptoms associated with osteoarthritis (OA) of the knee.
DTE Biomass Energy, subsidiary of $DTE, acquired 2 landfill gas-to-energy projects in Texas, purchasing both the operating Fort Bend Power Producers, LLC facility just outside of Rosenberg and the Seabreeze landfill gas development project in Angleton. Construction of the Seabreeze plant is expected to commence next month.
$SAFM's St. Pauls, North Carolina facility is progressing well and the company expects to reach full production during 1Q18. Additionally, $SAFM is scheduled to begin construction of its new Tyler, Texas, facility in 3Q17 and expects to open the facility during 1Q19.